Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
10
2025
 REACH and GHS in Latin America — A Conversation with Melissa Owen [PODCAST] Bergeson & Campbell, P.C.
Apr
10
2025
 Pennsylvania Federal Court Follows State Ruling That Medical Marijuana Use Is Not a Disability Under State Law Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
10
2025
 A Texas Federal Court Sides with Laboratories, But There May Be Unintended Consequences for FDA Mintz
Apr
9
2025
 EC Scientific Committee Begins Public Consultation on Preliminary Opinion on Hydroxyapatite (Nano) Bergeson & Campbell, P.C.
Apr
9
2025
 New Mexico Becomes Third State in the U.S. to Legalize Access to Psilocybin Foley & Lardner LLP
Apr
9
2025
 Sick of Healthcare? Healthcare Benefit Update for Employers – What to Watch in 2025 Babst, Calland, Clements & Zomnir, P.C.
Apr
8
2025
 EPA Announces Changes to Pesticide Data Submission Process for Data Matrix Form Bergeson & Campbell, P.C.
Apr
8
2025
 The LDT Final Rule Bites the Dust: Examining the Repercussions of the Federal Court’s Vacatur and What the Future May Hold Epstein Becker & Green, P.C.
Apr
8
2025
 Litigation Minute: Emerging Contaminants: Defending Litigation K&L Gates LLP
Apr
7
2025
 Old North State Report – April 7, 2025 Nelson Mullins
Apr
7
2025
 NSF Announces PFAS-Free Certification for Nonfood Compounds and Food Equipment Materials Bergeson & Campbell, P.C.
Apr
7
2025
 Healthcare Preview for the Week of: April 7, 2025 [Podcast] McDermott Will & Emery
Apr
7
2025
 Jepson Claim Format Does Not Avoid Written Description Scrutiny Foley & Lardner LLP
Apr
7
2025
 LDT Final Rule Series: Part 4 – Rule Overturned by Federal District Court Sheppard, Mullin, Richter & Hampton LLP
Apr
4
2025
 Unlocking the Secrets of the Endocannabinoid System: A New Frontier in Therapeutic Cannabis Research for Adolescents Womble Bond Dickinson (US) LLP
Apr
4
2025
 Two Class Actions Target Supplement Promoted for Increasing GLP-1 Keller and Heckman LLP
Apr
4
2025
 Mexico Bans the Cultivation of Genetically Modified Corn, Opening Door for Other Restrictions in the Future Beveridge & Diamond PC
Apr
4
2025
 Court Rejects Challenge to FDA Approval of Ammonia-Reducing Animal Drug Keller and Heckman LLP
Apr
4
2025
 Texas Senate Approves Two Bills Aimed at Artificial Food Additives Keller and Heckman LLP
Apr
4
2025
 Summary Judgment Granted in Heavy Metals in Chocolate Class Action Keller and Heckman LLP
Apr
3
2025
 Hatch-Waxman Litigation Expenses Are Deductible Under Internal Revenue Code § 162(a) McDermott Will & Emery
Apr
3
2025
 Court Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS Today Epstein Becker & Green, P.C.
Apr
3
2025
 Supreme Court Rules Lost Wages May Be Recoverable Under RICO For False Advertising After Drug Test Dismissal Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
2
2025
 USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program Bergeson & Campbell, P.C.
Apr
2
2025
 GLP-1 Receptor Agonists: Drug Litigation Overview and Trends Foley & Lardner LLP
Apr
2
2025
 March 2025 PFAS Legislative Developments CMBG3 Law
Apr
2
2025
 Texas Court Vacates FDA’s Laboratory Developed Test (LDT) Final Rule Foley & Lardner LLP
Apr
1
2025
 In Landmark Ruling, Eastern District of Texas Strikes Down FDA’s Final Rule Regulating Laboratory Developed Tests Polsinelli PC
Displaying 1 - 28 of 12128
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters